SEC Form 4 · accession 0001140361-15-014309
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 1:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 1, 2015 | M | 22,546 | $6.46 | A | 55,804 | I | Shares held by Bienaime Family Trust |
| Common StockF1,F3,F2 | Apr 1, 2015 | S | 22,546 | $120.5334 | D | 33,258 | I | Shares held by Bienaime Family Trust |
| Common StockF3 | Apr 1, 2015 | S | 3,506 | $120.5334 | D | 251,251 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF2,F4,F5 | $6.46 | Apr 1, 2015 | M | 22,546 | D | Nov 11, 2005 | May 10, 2015 | Common Stock | 22,546 | 23,218 | I |
Explanation of responses
- F1Trade made pursuant to a 10b5-1 plan executed October 28, 2014.
- F2The reporting person an his spouse act as trustees for the Bienaime Family Trust
- F3The price in column 4 is an average weighted price. The price actually received ranged from $118.4 to $124.61. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- F4Original option grant vests 6/48th on November 11, 2005, and 1/48th on the 11th day of every month thereafter.
- F5Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.